Noah Medical
Noah Medical's Galaxy System is a navigated robotic bronchoscopy platform. It combines TiLT+ technology (integrated tomosynthesis and augmented fluoroscopy) with a single-use disposable bronchoscope, and it is used for minimally invasive lung biopsy. It sells to hospitals and interventional pulmonologists and thoracic surgeons. The company received FDA clearance in March 2023, raised a $150M Series B led by SoftBank Vision Fund and Prosperity7 in April 2023, and performed its first US commercial procedure in May 2023. PitchBook lists about 309 employees in 2026 and a later Series B1 of $230M, which I could not confirm from a primary source.
Funding
Every round, secondary, debt facility or acquisition involving Noah Medical that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in